- Development of new medicine radionuclides production technology (Ge-68, Lu-177, At-211, Sr/Rb-82, Ac-225) at charged particle accelerators.- Mathematical modeling of target parameters for production nuclear medicine radionuclides using SolidWorks, ANSYS, COMSOL, Talys, SRIM software components.- Formation of technical requirements to equipment used for production of medical radionuclides.

• Ensured the launch of the new FDG production. Participated in the preparation of the building for the start-up of production equipment. In cooperation with IBA and COMECER engineers, installed the cyclotron, hot cells, synthesis modules and dosimetry system. Developed working documentation • Operating IBA Kuibe 180 cyclotron for F-18 production. Maintain uninterrupted FDG production. • Maintenance of the cyclotron and related systems: vacuum, RF. Ion source, magnet, liquid target as well as COMECER hot cells. Synthera and Fast lab modules. • Providing radiation safety at the cyclotron, accounting and control of radioactive substances and radioactive waste.

• Conducting research on new radiopharmaceuticals producing (I-124, Re-186, At-211, In-111, Ge-68). • Developing new way for solid target cooling during irradiation on cyclotron. Receive a patent № RU 2 777 655 C1. Due to the innovation it is possible to reduce the cost of iodine-123/124 radiopharmaceuticals by 25%. • Operating and maintenance R7M cyclotron and related systems: vacuum, RF, ion source, main magnet, target assembly. • Collaborated with other engineers to design a target assembly for irradiation of polymer films with a beam of alpha particles.